2021
DOI: 10.1186/s13098-021-00624-9
|View full text |Cite
|
Sign up to set email alerts
|

Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis

Abstract: Background Diabetes mellitus (DM) could be classified as type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), gestational diabetes mellitus (GDM) and others according to etiology and pathology. Diabetic nephropathy (DN) is one of the most serious complications of DM. YKL-40 is a marker of inflammation and some studies have indicated that DM was related with inflammation. The objective of our study is to perform a systematic review and meta-analysis to confirm the relationship betwe… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 46 publications
(36 reference statements)
0
3
0
2
Order By: Relevance
“…YKL-40 and chitotriosidase belong to the same family, “mammalian chitinase-like proteins,” but YKL-40 is not a chitinase; rather, it binds tightly to chitin particles [ 28 ]. YKL-40 is a potential serum biomarker of distinct benign and malignant disease states, including diabetes mellitus, coronary artery disease, systemic sclerosis, psoriasis, dementia, benign prostatic hyperplasia, cervical cancer, and primary prostate cancer [ 14 17 , 28 , 29 ]. Unfortunately, there is scarce evidence for an association between YKL-40 and AP.…”
Section: Discussionmentioning
confidence: 99%
“…YKL-40 and chitotriosidase belong to the same family, “mammalian chitinase-like proteins,” but YKL-40 is not a chitinase; rather, it binds tightly to chitin particles [ 28 ]. YKL-40 is a potential serum biomarker of distinct benign and malignant disease states, including diabetes mellitus, coronary artery disease, systemic sclerosis, psoriasis, dementia, benign prostatic hyperplasia, cervical cancer, and primary prostate cancer [ 14 17 , 28 , 29 ]. Unfortunately, there is scarce evidence for an association between YKL-40 and AP.…”
Section: Discussionmentioning
confidence: 99%
“…Higher serum concentrations of YKL-40 are associ-ated with severe forms of the inflammatory diseases and consequently poorer prognosis, implicating its potential role as a biological marker in the prediction of the inflammatory response severity (37,(45)(46)(47)(48)(49)(50)(51)(52)(53)(54)(55)(56)(57). Results of recent human studies in patients and healthy controls are presented in Figure 2.…”
Section: Laboratory Methods and Measurement Of Ykl-40mentioning
confidence: 99%
“…YKL-40 plasma concentrations are 2-3 times higher both in patients with type 1 and type 2 DM compared to the normoglycemia group (48,69). In type 2 DM patients with concurrent obesity, YKL-40 influences insulin sensitivity through the stimulation of inflammatory chemokines production in activated adipose tissue macrophages (69).…”
Section: Endocrine Systemmentioning
confidence: 98%
“…País Hallazgos (Luo, 2021) 2017 China Los pacientes con DM2 y aquellos con albuminuria, chinos o no chinos, tenían niveles elevados de factor de crecimiento transformante beta 1 (TGF-β1) en suero y orina. (Mansoor , 2020) 2019 África La comparación de métodos para la medición de la creatinina para evaluar la función renal (Penno, 2018) 2020 Corea…”
Section: Referencia Añounclassified
“…También la glicoproteína de unión a quitina de 40 KDa (YKL-40) tiene funciones biológicas que aún se desconocen. Se considera un marcador inflamatorio e indicador de disfunción endotelial, que se encuentra elevado en la DM2 y la DM1 y aumenta junto con la albuminuria (Luo, 2021).…”
Section: Introductionunclassified